Metabolic Syndrome And Related Disorders

Journal Title：Metabolic Syndrome And Related Disorders

Metabolic Syndrome and Related Disorders is the only peer-reviewed journal focusing solely on the pathophysiology, recognition, and treatment of this major health condition. The Journal meets the imperative for comprehensive research, data, and commentary on metabolic disorder as a suspected precursor to a wide range of diseases, including type 2 diabetes, cardiovascular disease, stroke, cancer, polycystic ovary syndrome, gout, and asthma.

Metabolic Syndrome and Related Disorders coverage includes:

-Insulin resistance-

Central obesity-

Glucose intolerance-

Dyslipidemia with elevated triglycerides-

Low HDL-cholesterol-

Microalbuminuria-

Predominance of small dense LDL-cholesterol particles-

Hypertension-

Endothelial dysfunction-

Oxidative stress-

Inflammation-

Related disorders of polycystic ovarian syndrome, fatty liver disease (NASH), and gout

Metabolic Syndrome and Related Disorders 是唯一一本专注于这一主要健康状况的病理生理学、识别和治疗的同行评审期刊。该杂志满足了对代谢紊乱进行全面研究、数据和评论的必要性，代谢紊乱是多种疾病的疑似前兆，包括 2 型糖尿病、心血管疾病、中风、癌症、多囊卵巢综合征、痛风和哮喘。

代谢综合征和相关疾病的覆盖范围包括：

-胰岛素抵抗-

中枢性肥胖-

葡萄糖不耐受-

甘油三酯升高的血脂异常-

低 HDL-胆固醇-

微量白蛋白尿-

以小而致密的低密度脂蛋白胆固醇颗粒为主-

高血压-

内皮功能障碍-

氧化应激-

炎症-

多囊卵巢综合征、脂肪肝疾病 (NASH) 和痛风的相关疾病

Metabolic Syndrome And Related Disorders创刊于2003年，由MARY ANN LIEBERT, INC出版商出版，收稿方向涵盖MEDICINE, RESEARCH & EXPERIMENTAL全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度较慢,6-12周，影响因子指数1.654，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。